147 related articles for article (PubMed ID: 35660228)
1. Role of Telemedicine in Improving Guideline-Directed Medical Treatment for Patients with Heart Failure During a Pandemic.
Hernandez LS
Crit Care Nurs Clin North Am; 2022 Jun; 34(2):151-156. PubMed ID: 35660228
[TBL] [Abstract][Full Text] [Related]
2. The Role of Nurse Practitioners in the Management of Heart Failure Patients and Programs.
King-Dailey K; Frazier S; Bressler S; King-Wilson J
Curr Cardiol Rep; 2022 Dec; 24(12):1945-1956. PubMed ID: 36434405
[TBL] [Abstract][Full Text] [Related]
3. The design of the Dashboard Activated Services and Telehealth for Heart Failure (DASH-HF) study: A pragmatic quality improvement randomized implementation trial for patients with heart failure with reduced ejection fraction.
Verma A; Fonarow GC; Hsu JJ; Jackevicius CA; Mody FV; Amidi O; Goldberg S; Upparapalli D; Theodoropoulos K; Gregorio S; Chang DS; Bostrom K; Althouse AD; Ziaeian B
Contemp Clin Trials; 2022 Sep; 120():106895. PubMed ID: 36028192
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers about treatment of heart failure (PROMPT-HF).
Ghazi L; Desai NR; Simonov M; Yamamoto Y; O'Connor KD; Riello RJ; Huang J; Olufade T; McDermott J; Inzucchi SE; Velazquez EJ; Wilson FP; Ahmad T
Am Heart J; 2022 Feb; 244():107-115. PubMed ID: 34808104
[TBL] [Abstract][Full Text] [Related]
5. Digital Solutions to Optimize Guideline-Directed Medical Therapy Prescriptions in Heart Failure Patients: Current Applications and Future Directions.
Man JP; Klopotowska J; Asselbergs FW; Handoko ML; Chamuleau SAJ; Schuuring MJ
Curr Heart Fail Rep; 2024 Apr; 21(2):147-161. PubMed ID: 38363516
[TBL] [Abstract][Full Text] [Related]
6. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure.
Shahid I; Khan MS; Fonarow GC; Butler J; Greene SJ
Prog Cardiovasc Dis; 2024; 82():61-69. PubMed ID: 38244825
[TBL] [Abstract][Full Text] [Related]
7. Improving heart failure care and guideline-directed medical therapy through proactive remote patient monitoring-home telehealth and pharmacy integration.
Lynch KA; Ganz DA; Saliba D; Chang DS; de Peralta SS
BMJ Open Qual; 2022 Jul; 11(3):. PubMed ID: 35902181
[TBL] [Abstract][Full Text] [Related]
8. Outpatient Management of Guideline-Directed Medical Therapy for Heart Failure Using Telehealth: A Comparison of In-Office, Video, and Telephone Visits.
Sammour Y; Main ML; Austin BA; Magalski A; Sperry BW
J Card Fail; 2022 Jul; 28(7):1222-1226. PubMed ID: 35318127
[TBL] [Abstract][Full Text] [Related]
9. Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Desai AS; Maclean T; Blood AJ; Bosque-Hamilton J; Dunning J; Fischer C; Fera L; Smith KV; Wagholikar K; Zelle D; Gaziano T; Plutzky J; Scirica B; MacRae CA
JAMA Cardiol; 2020 Dec; 5(12):1430-1434. PubMed ID: 32936209
[TBL] [Abstract][Full Text] [Related]
10. Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline-directed medical therapy in heart failure with reduced ejection fraction.
Seferović PM; Polovina M; Adlbrecht C; Bělohlávek J; Chioncel O; Goncalvesová E; Milinković I; Grupper A; Halmosi R; Kamzola G; Koskinas KC; Lopatin Y; Parkhomenko A; Põder P; Ristić AD; Šakalytė G; Trbušić M; Tundybayeva M; Vrtovec B; Yotov YT; Miličić D; Ponikowski P; Metra M; Rosano G; Coats AJS
Eur J Heart Fail; 2021 Dec; 23(12):1999-2007. PubMed ID: 34755422
[TBL] [Abstract][Full Text] [Related]
11. Impact of telemedicine on the management of heart failure patients during coronavirus disease 2019 pandemic.
Afonso Nogueira M; Ferreira F; Raposo AF; Mónica L; Simões Dias S; Vasconcellos R; Proença G
ESC Heart Fail; 2021 Apr; 8(2):1150-1155. PubMed ID: 33560597
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of a navigator-driven remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
Blood AJ; Fischer CM; Fera LE; MacLean TE; Smith KV; Dunning JR; Bosque-Hamilton JW; Aronson SJ; Gaziano TA; MacRae CA; Matta LS; Mercurio-Pinto AA; Murphy SN; Scirica BM; Wagholikar K; Desai AS
Clin Cardiol; 2020 Jan; 43(1):4-13. PubMed ID: 31725920
[TBL] [Abstract][Full Text] [Related]
13. An NP-led pilot telehealth programme to facilitate guideline-directed medical therapy for heart failure with reduced ejection fraction during the COVID-19 pandemic.
McLachlan A; Aldridge C; Morgan M; Lund M; Gabriel R; Malez V
N Z Med J; 2021 Jul; 134(1538):77-88. PubMed ID: 34239147
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
[TBL] [Abstract][Full Text] [Related]
15. Multimorbidity, guideline-directed medical therapies, and associated outcomes among hospitalized heart failure patients.
Takeuchi S; Kohno T; Goda A; Shiraishi Y; Kawana M; Saji M; Nagatomo Y; Nishihata Y; Takei M; Nakano S; Soejima K; Kohsaka S; Yoshikawa T;
ESC Heart Fail; 2022 Aug; 9(4):2500-2510. PubMed ID: 35561100
[TBL] [Abstract][Full Text] [Related]
16. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
[TBL] [Abstract][Full Text] [Related]
17. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.
Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC
JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579
[TBL] [Abstract][Full Text] [Related]
18. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial.
Allen LA; Venechuk G; McIlvennan CK; Page RL; Knoepke CE; Helmkamp LJ; Khazanie P; Peterson PN; Pierce K; Harger G; Thompson JS; Dow TJ; Richards L; Huang J; Strader JR; Trinkley KE; Kao DP; Magid DJ; Buttrick PM; Matlock DD
Circulation; 2021 Feb; 143(5):427-437. PubMed ID: 33201741
[TBL] [Abstract][Full Text] [Related]
19. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
[TBL] [Abstract][Full Text] [Related]
20. Representativeness of the GALACTIC-HF Clinical Trial in Patients Having Heart Failure With Reduced Ejection Fraction.
Mefford MT; Koyama SY; De Jesus J; Wei R; Fischer H; Harrison TN; Woo P; Reynolds K
J Am Heart Assoc; 2022 Apr; 11(7):e023766. PubMed ID: 35322672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
